CoQ10 Supplementation in ICU patients

JRCT ID: jRCTs041180143

Registered date:29/03/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Valvular heart disease
• Date of first enrollment: 29/03/2019
• Target sample size: 40
• Countries of recruitment: The United States of America,Japan
• Study type: Interventional
• Intervention(s): Supplementation of reduced CoQ10

Outcome(s)

• Primary Outcome: Plasma and intracellular coenzyme Q10 levels
• Secondary Outcome: Clinical data

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Preoperative patients for cardiovascular surgery using cardiopulmonary bypass with postoperative admission to the ICU.
• Exclude criteria: Pregnant women, patients unable to communicate and patients with soy beans allergy.

Related Information

• Primary Sponsor: Nishida Osamu